Joinstar COVID-19 Antigen

142727
The Joinstar COVID-19 antigen lateral flow test (colloidal gold) is used for self-testing of acute SARS-CoV-2 infections. The particularly gentle and less invasive sample collection in the anterior nasal region can be carried out by the user without any problems.
Delivery: 
CN
minimum order: 
20 wp
Supply Ability: 
3213wp / Quarterly
Country of Origin: 
China
Stock Time: 
2Day
Quantity:
Contact Now
 

Joinstar COVID-19 Antigen Lateral Flow Test (Colloidal Gold)

The Joinstar COVID-19 antigen lateral flow test (colloidal gold) is used for self-testing of acute SARS-CoV-2 infections. The particularly gentle and less invasive sample collection in the anterior nasal region can be carried out by the user without any problems.

Thanks to its high sensitivity and specificity, the antigen test provides a reliable test result that can be read after only 15 minutes. As the extraction tubes are already pre-filled with the buffer solution, the test procedure is particularly convenient and one of the most frequent sources of error in the test procedure is eliminated.
  • Joinstar COVID-19 Antigen lateral flow test (colloidal gold)
  • Self-test for the detection of acute SARS-CoV infections
  • COVID-19 rapid test (colloidal gold) for self-testing
  • Qualitative detection of SARS-CoV-2 nucleocapsid antigen
  • Test method: anterior nasal swab
  • Particularly gentle, easy-to-perform test procedure
  • Sensitivity: 96.1 %
  • Specificity: 99.2 %
  • No cross-reactivity with common pathogens such as H1N1, Influenza A/B, RSV, MERS-CoV or Streptococcus pneumoniae
  • Simple test procedure thanks to pre-filled extraction tubes
  • Test result available after only 15 minutes
  • With CE marking
  • Complies with EN ISO 13485:2016
  • Easy to read result
  • Please note that this rapid test is excluded from the right of return
  • Optionally with 5 or 25 test kits
 
 
Joinstar COVID-19 antigen self-test available in different pack sizes
 
 
 
  • Extended QC (eQC): with onboard bias, precision and accuracy monitoring without the need for internet or extra fees
  • Reduce administrative errors and go paperless:: designed to work as hard as you do, the onboard data management in the DxH 560 can host up to 30,000 patient records—equivalent to a year’s worth of tests with typical usage
  • Keep analysis running smoothly throughout the day: store and manage just three reagents, with simple and quick replacement, compared to six reagents with other analyzers in its class
  • Test in tight spaces: with an integrated monitor and keyboard and only one external reagent, the DxH 560 requires up to 1/3 less laboratory counter space than other analyzers in its class

Deliver secure, high-quality, confident results with fewer unnecessary slide reviews within secure, expanded patient database capability

Ensure a more accurate 5-part differential with sophisticated flow cytometry with proprietary dynamic gating technology that reduces flagging by 40% compared to static gating. The sophisticated gating technology in the DxH 560 improves the identification of white blood cells (WBC) populations by automatically adjusting the thresholds between cell-cluster arrangements.(Figures 2a and 2b). More reportable results are seen with more challenging cell populations, such as lymphocytes and eosinophils, giving a more accurate 5-part leukocyte differential than static gating.